dr. stinchcombe on remaining challenges in alk nsclc
Published 4 years ago • 115 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
0:52
dr. stinchcombe on the benefit of alectinib in alk nsclc
-
0:53
dr. stinchcombe discusses differences in toxicity profiles among alk inhibitors in nsclc
-
1:05
dr. stinchcombe on molecular testing in alk nsclc
-
0:56
dr. stinchcombe on the alta-1l trial in alk nsclc
-
1:25
dr. kerrigan on remaining challenges in alk nsclc
-
1:10
dr. stinchcombe on advances in targeted therapies in nsclc
-
1:08
dr. stinchcombe on the keynote-189 trial in lung cancer
-
1:41
dr. pennell on remaining challenges in nsclc
-
0:59
dr. kerrigan on remaining challenges in ros1 nsclc
-
1:34
dr. camidge on the alta study of brigatinib in nsclc
-
0:51
dr. stinchcombe discusses the pacific trial for nsclc
-
1:05
dr. aggarwal on emerging treatment approaches in alk nsclc
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
1:57
dr. shaw on sequencing strategies in alk-positive nsclc
-
1:22
dr. bauml on the use of immunotherapy in oligometastatic nsclc
-
18:09
dr vamshi krishna | certinib - a frontier in the 1st line treatment of alk ve nsclc
-
1:03
dr. thomas stinchcombe on targeted therapies in squamous cell lung cancer
-
13:06
challenges in first line alk positive nsclc management and emerging data on alk tkis in alk posi...
-
1:42
dr. velcheti on potential of alectinib in frontline alk-positive nsclc